Ovarian Epithelial Carcinoma Clinical Trial
Official title:
Single-arm, Open-label Clinical Study of SZ011 in the Treatment of Ovarian Epithelial
This study was a single-center, open-label, investigator-initiated clinical trial (IIT) to observe and investigate the clinical safety and efficacy of SZ011 in the treatment of ovarian epithelial carcinoma
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01536743 -
A Open Label Study of the Efficacy and Safety of PD0332991 a Selective Inhibitor of the Cyclin Dependent Kinases 4 and 6 in Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency and Low p16 Expression
|
Phase 2 | |
Recruiting |
NCT05763199 -
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy
|
Phase 2 | |
Recruiting |
NCT04794322 -
Developing a Test for the Detection of Ovarian Cancer
|